OpenURL Connection Search

Select item for more details and to access through your institution.

Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics.
Published in:
NPJ Parkinson's Disease, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0040-2
By:
- Standaert, David G.;
- Boyd, James T.;
- Odin, Per;
- Robieson, Weining Z.;
- Zamudio, Jorge;
- Chatamra, Krai
Publication type:
Article
Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.
Published in:
2019
By:
- Quik, Maryka;
- Boyd, James T;
- Bordia, Tanuja;
- Perez, Xiomara
Publication type:
journal article
Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of Levodopa.
Published in:
Parkinson's Disease (20420080), 2020, p. 1, doi. 10.1155/2020/9716317
By:
- Zadikoff, Cindy;
- Poewe, Werner;
- Boyd, James T.;
- Bergmann, Lars;
- Ijacu, Horia;
- Kukreja, Pavnit;
- Robieson, Weining Z.;
- Benesh, Janet;
- Antonini, Angelo
Publication type:
Article
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
Published in:
2018
By:
- Fernandez, Hubert H.;
- Boyd, James T.;
- Fung, Victor S. C.;
- Lew, Mark F.;
- Rodriguez, Ramon L.;
- Slevin, John T.;
- Standaert, David G.;
- Zadikoff, Cindy;
- Vanagunas, Arvydas D.;
- Chatamra, Krai;
- Eaton, Susan;
- Facheris, Maurizio F.;
- Hall, Coleen;
- Robieson, Weining Z.;
- Benesh, Janet;
- Espay, Alberto J.
Publication type:
journal article
Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials.
Published in:
2016
By:
- Lang, Anthony E.;
- Rodriguez, Ramon L.;
- Boyd, James T.;
- Chouinard, Sylvain;
- Zadikoff, Cindy;
- Espay, Alberto J.;
- Slevin, John T.;
- Fernandez, Hubert H.;
- Lew, Mark F.;
- Stein, David A.;
- Odin, Per;
- Fung, Victor S.C.;
- Klostermann, Fabian;
- Fasano, Alfonso;
- Draganov, Peter V.;
- Schmulewitz, Nathan;
- Robieson, Weining Z.;
- Eaton, Susan;
- Chatamra, Krai;
- Benesh, Janet A.
Publication type:
journal article
Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.
Published in:
2016
By:
- Antonini, Angelo;
- Fung, Victor S. C.;
- Boyd, James T.;
- Slevin, John T.;
- Hall, Coleen;
- Chatamra, Krai;
- Eaton, Susan;
- Benesh, Janet A.
Publication type:
journal article

Found: 6

Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics.

Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of Levodopa.

Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.

Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials.

Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.